Impact of Iron Deficiency on Peripheral Artery Disease After Endovascular Therapy.
Despite advances in endovascular therapy (EVT), peripheral artery disease (PAD) is a public health problem associated with high cardiovascular mortality. Iron deficiency (ID) is associated with poor clinical outcome in patients with heart disease, but whether ID is associated with the severity and clinical outcome of PAD remains unclear.  A total of 449 patients with PAD who received EVT and who had iron and red blood cell measurement were enrolled. ID was defined as transferrin saturation (TSAT) <20%, based on a previous report. TSAT and hemoglobin decreased with deteriorating Fontaine class. During a median follow-up period of 1,064 days, 71 major adverse cardiovascular and leg events (MACLE) and 47 major adverse cardiovascular events (MACE) were noted. All patients were divided into 2 groups based on the presence of ID. On Kaplan-Meier analysis, patients with ID had higher rates of MACE and MACLE than those without. On multivariate Cox proportional hazard regression analysis, TSAT and hemoglobin were independently associated with MACLE. Addition of TSAT to the known risk factors significantly improved the net reclassification index and integrated discrimination improvement.  ID, as assessed by TSAT, was associated with the severity and clinical outcome of PAD, indicating that it could be a therapeutic target.
['Otaki|Yoichiro|Y|', 'Watanabe|Tetsu|T|', 'Takahashi|Hiroki|H|', 'Sugai|Takayuki|T|', 'Yokoyama|Miyuki|M|', 'Tamura|Harutoshi|H|', 'Kato|Shigehiko|S|', 'Nishiyama|Satoshi|S|', 'Arimoto|Takanori|T|', 'Shishido|Tetsuro|T|', 'Watanabe|Masafumi|M|']
Iron deficiency Peripheral artery disease Clinical outcome